[1]
Rauf, A., Alam, W., Khan, M., W. Darwish, H., Daglia, M., A. Elhenawy, A. and Khan, H. 2025. Exploring the in vitro anti-diabetic potential and in silico studies of 2, 3 and 2, 6-dichloroIndolinone. Drug Target Insights. 19, 1 (Mar. 2025), 11–17. DOI:https://doi.org/10.33393/dti.2025.3271.